T-DM1
Term · Oncology and biomedicine · MLC-T-ONC-008559
A drug used to treat certain patients with HER2-positive breast cancer that has already been treated with trastuzumab and a type of anticancer drug called a taxane. It is also being studied in the treatment of other types of cancer. T-DM1 contains a monoclonal antibody called trastuzumab that binds to a protein called HER2, which is found on some breast cancer cells. It also contains an anticancer drug called DM1, which may help kill cancer cells. T-DM1 is a type of antibody-drug conjugate. Also called ado-trastuzumab emtansine and Kadcyla.
| Identifier | MLC-T-ONC-008559 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | ado-trastuzumab emtansine; Kadcyla |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-008559",
"term": "T-DM1",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat certain patients with HER2-positive breast cancer that has already been treated with trastuzumab and a type of anticancer drug called a taxane. It is also being studied in the treatment of other types of cancer. T-DM1 contains a monoclonal antibody called trastuzumab that binds to a protein called HER2, which is found on some breast cancer cells. It also contains an anticancer drug called DM1, which may help kill cancer cells. T-DM1 is a type of antibody-drug conjugate. Also called ado-trastuzumab emtansine and Kadcyla.",
"expansions": [
"ado-trastuzumab emtansine",
"Kadcyla"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/t-dm1/"
}
Record 16,048 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.